Clinical Cancer Research The Science of Cancer Health Disparities Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, Z.
Right arrow Articles by Shao, Z.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, Z.
Right arrow Articles by Shao, Z.-M.
Clinical Cancer Research Vol. 8, 2085-2090, July 2002
© 2002 American Association for Cancer Research

Molecular Oncology, Markers, Clinical Correlates

The Tumor Suppressor Gene LKB1 Is Associated with Prognosis in Human Breast Carcinoma1

Zan Shen, Xian-Feng Wen, Fei Lan, Zhen-Zhou Shen and Zhi-Ming Shao2

Department of Surgery, Cancer Hospital/Cancer Institute, Fudan University, Shanghai 200032, People’s Republic of China [Z. S., X-F. W., F. L., Z-Z. S., Z-M. S.]

Purpose: LKB1 (also called STK11) is a recently identified tumor suppressor gene in which its mutation can lead to Peutz-Jeghers syndrome, characterized by gastrointestinal polyps and cancers of different organ systems. Weak expression of this gene does occur at a certain frequency in sporadic breast cancer. This indicates that LKB1 gene may relate to the tumorigenesis of breast cancer.

Experimental Design: To investigate the function of the LKB1 gene in sporadic breast cancer, we reintroduced LKB1 into breast cancer cell lines which lack the LKB1 gene. Also, we examined the LKB1 protein expression in human breast cancer samples.

Results: We found that reintroducing LKB1 into breast cancer cell lines suppresses cell growth by G1 cell cycle block. The LKB1-mediated G1 cell cycle arrest is caused by up-regulation of the expression of p21WAF1/CIP1 in breast cancer MDA-MB-435 cells. We also demonstrated that low LKB1 protein expression correlates with higher histological grade (P = 0.013), larger tumor size (P = 0.001), progesterone receptor status (P = 0.048), and presence of lymph node metastasis (P = 0.003). Furthermore, LKB1 low expression was associated with a higher relapse rate (P = 0.002) and a worse OS (P = 0.008).

Conclusions: LKB1 plays a role in tumor suppressor function in human breast cancer. LKB1 expression may be a useful prognostic marker in human breast cancer.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
R. J.O. Dowling, M. Zakikhani, I. G. Fantus, M. Pollak, and N. Sonenberg
Metformin Inhibits Mammalian Target of Rapamycin Dependent Translation Initiation in Breast Cancer Cells
Cancer Res., November 15, 2007; 67(22): 10804 - 10812.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
G. Kroemer, L. Galluzzi, and C. Brenner
Mitochondrial Membrane Permeabilization in Cell Death
Physiol Rev, January 1, 2007; 87(1): 99 - 163.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
Z.-G. Zhuang, G.-H. Di, Z.-Z. Shen, J. Ding, and Z.-M. Shao
Enhanced Expression of LKB1 in Breast Cancer Cells Attenuates Angiogenesis, Invasion, and Metastatic Potential
Mol. Cancer Res., November 1, 2006; 4(11): 843 - 849.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. M. Wagner, J. E. Mullally, and F. A. Fitzpatrick
Reactive Lipid Species from Cyclooxygenase-2 Inactivate Tumor Suppressor LKB1/STK11: CYCLOPENTENONE PROSTAGLANDINS AND 4-HYDROXY-2-NONENAL COVALENTLY MODIFY AND INHIBIT THE AMP-KINASE KINASE THAT MODULATES CELLULAR ENERGY HOMEOSTASIS AND PROTEIN TRANSLATION
J. Biol. Chem., February 3, 2006; 281(5): 2598 - 2604.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. Forcet, S. Etienne-Manneville, H. Gaude, L. Fournier, S. Debilly, M. Salmi, A. Baas, S. Olschwang, H. Clevers, and M. Billaud
Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity
Hum. Mol. Genet., May 15, 2005; 14(10): 1283 - 1292.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. V. Swinnen, A. Beckers, K. Brusselmans, S. Organe, J. Segers, L. Timmermans, F. Vanderhoydonc, L. Deboel, R. Derua, E. Waelkens, et al.
Mimicry of a Cellular Low Energy Status Blocks Tumor Cell Anabolism and Suppresses the Malignant Phenotype
Cancer Res., March 15, 2005; 65(6): 2441 - 2448.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
P A Marignani
LKB1, the multitasking tumour suppressor kinase
J. Clin. Pathol., January 1, 2005; 58(1): 15 - 19.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Raguz, M. Tamburo De Bella, G. Tripuraneni, M. J. Slade, C. F. Higgins, R. C. Coombes, and E. Yague
Activation of the MDR1 Upstream Promoter in Breast Carcinoma as a Surrogate for Metastatic Invasion
Clin. Cancer Res., April 15, 2004; 10(8): 2776 - 2783.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.